Scott Koenig

USPTO Granted Patents = 56 (Patent Applications = 27)

CIPO Patents = 7 (Patent Applications = 14)

EPO Patents = 15 (Patent Applications = 29)

Average Co-Inventor Count = 2.9

ph-index = 20

Forward Citations = 1,053(Granted Patents)

Forward Citations (Not Self Cited) = 947(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Stewart Manor, NY (US) (1995)
Brooklyn, NY (US) (2014 - 2015)
Rockville, MD (US) (2002 - 2024)

Company Filing History:

St. Jude Children's Research Hospital

patents

5. 2 out of 1,271

The University of North Carolina at Chapel Hill

patents

6. 1 out of 932

The University of British Columbia

patents

7. 4 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2024

Loading Chart...

Areas of Expertise:

Bispecific Molecules

HIV-1 Envelope

LAG-3-Binding Molecules

PD-1-Binding Molecules

Combination Therapy

Immunoglobulins

Monoclonal Antibodies

FcγRIIB Specific Antibodies

Vaccine Development

Immunogenic Activity

Choline Binding Proteins

Cancer Treatment

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12173051 - Bispecific molecules comprising an HIV-1 envelope targeting arm (2024-12-24),

2. 11858991 - LAG-3-binding molecules and methods of use thereof (2024-01-02),

3. 11840571 - Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4 (2023-12-12),

4. 11787871 - Methods for the treatment of disease using immunoglobulins having fc regions with altered affinities for FcgammaRactivating and FegammaRinhibiting (2023-10-17),

5. 11639386 - Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof (2023-05-02),

6. 11623959 - PD-1-binding molecules and methods of use thereof (2023-04-11),

7. 11421031 - Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof (2022-08-23),

8. 11174315 - Combination therapy for the treatment of cancer (2021-11-16),

9. 11098119 - Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof (2021-08-24),

10. 11078279 - Combination therapy for the treatment of cancer (2021-08-03),

11. 11072653 - LAG-3-binding molecules and methods of use thereof (2021-07-27),

12. 10954301 - Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof (2021-03-23),

13. 10730947 - Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof (2020-08-04),

14. 10717778 - Bispecific molecules comprising an HIV-1 envelope targeting arm (2020-07-21),

15. 10711069 - Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRand FcγR (2020-07-14),

Title: The Innovative Journey of Scott Koenig

Introduction: Scott Koenig, a talented inventor based in Rockville, MD, has made significant contributions to the field of technology through his creative and groundbreaking ideas.

Latest Patents: Scott Koenig holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices, showcasing his versatility and ingenuity in the innovation landscape.

Career Highlights: With a career spanning over two decades, Scott Koenig has worked with leading tech companies, where he spearheaded research and development projects that have resulted in cutting-edge inventions and solutions that have positively impacted industries and society as a whole.

Collaborations: Throughout his career, Scott Koenig has collaborated with top researchers, engineers, and scientists, both nationally and internationally, fostering a culture of innovation and knowledge exchange that has led to groundbreaking discoveries and advancements in technology.

Conclusion: Scott Koenig's passion for innovation, coupled with his dedication to pushing the boundaries of what is possible, continues to inspire the next generation of inventors and entrepreneurs to pursue their ideas fearlessly and make a lasting impact on the world.

This text is generated by artificial intelligence and may not be accurate.